Renovaro Biosciences Ownership | Who Owns Renovaro Biosciences?


OverviewRevenueFinancialsChart

Renovaro Biosciences Ownership Summary


Renovaro Biosciences is owned by 10.59% institutional investors, 51.33% insiders, and 38.08% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 4.15% of RENB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.06% of its assets in Renovaro Biosciences shares.

RENB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRenovaro Biosciences10.59%51.33%38.08%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.50M4.15%$5.43M
Vanguard group5.72M3.65%$4.78M
Geode capital management2.33M1.49%$1.95M
State street2.06M1.32%$1.73M
Ubs group763.70K0.49%$638.46K
Goldman sachs group364.48K0.23%$304.52K
Charles schwab investment management362.13K0.23%$302.56K
Jpmorgan chase353.83K0.23%$295.63K
Cantor fitzgerald, l. p.300.00K0.19%$250.65K
Bank of new york mellon223.91K0.14%$187.08K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Abel hall12.42K0.01%$10.38K
Msa advisors25.00K0.01%$20.89K
Cantor fitzgerald, l. p.300.00K0.01%$250.65K
Two sigma securities16.89K0.00%$14.12K
Xtx topco10.12K0.00%$8.46K
Vanguard personalized indexing management20.71K0.00%$17.30K
Ameritas investment partners12.10K0.00%$10.11K
Metlife investment management75.45K0.00%$63.04K
Corebridge financial57.49K0.00%$48.04K
Tower research capital llc (trc)12.22K0.00%$10.22K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de6.50M0.00%2.89M
Geode capital management2.33M0.00%760.34K
State street2.06M0.00%741.03K
Ubs group763.70K0.00%717.25K
Goldman sachs group364.48K-271.59K

Top Sellers

HolderShares% AssetsChange
Hsbc13.47K--41.72K
Paloma partners management---16.95K
New york state common retirement fund52.50K0.00%-14.20K
Y-intercept (hong kong)---12.37K
Jane street group10.32K--10.54K

New Positions

HolderShares% AssetsChangeValue
Deutsche bank ag\127.44K-127.44K$107.05K
Metlife investment management75.45K0.00%75.45K$63.04K
Manufacturers life insurance company, the45.80K-45.80K$38.26K
Voya investment management35.31K-35.31K$29.50K
Proshare advisors32.57K0.00%32.57K$27.21K

Sold Out

HolderChange
Royal bank of canada-5.57K
Victory capital management-10.28K
Y-intercept (hong kong)-12.37K
Paloma partners management-16.95K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202425-51.92%16,578,24912.30%1011.91%16-48.39%3-57.14%
Sep 30, 20245236.84%14,762,4084.27%94.36%3110.71%7-
Jun 30, 202438-11.63%14,157,44395.26%1432.32%28-3.45%7-12.50%
Mar 31, 20244319.44%7,250,533181.83%644.20%29-6.45%8166.67%
Dec 31, 20233656.52%2,572,67372.87%373.34%3155.00%3-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.34M2.06%-1.00
Vanguard Total Stock Mkt Idx Inv3.34M2.06%-
iShares Russell 2000 ETF2.93M1.80%-25.36K
Vanguard Institutional Extnd Mkt Idx Tr1.40M0.86%-
Fidelity Small Cap Index1.14M0.70%-21.27K
State St Russell Sm/Mid Cp® Indx NL Cl C940.16K0.58%-
State St Russell Sm/Mid Cp® Indx SL Cl I940.16K0.58%-
iShares Russell 2000 Growth ETF622.94K0.38%-2.96K
Vanguard Russell 2000 ETF524.45K0.32%12.32K
Fidelity Extended Market Index483.07K0.30%-3.08K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 29, 2024William Anderson Wittekind-Sell$1.45K
Jul 17, 2024William Anderson Wittekind-Sell$23.89K
Jul 15, 2024William Anderson Wittekind-Sell$30.96K
Jul 10, 2024William Anderson Wittekind-Sell$113.25K
Jul 11, 2024William Anderson Wittekind-Sell$22.49K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3-10
2024 Q2-4
2024 Q1--

RENB Ownership FAQ


Who Owns Renovaro Biosciences?

Renovaro Biosciences shareholders are primarily institutional investors at 10.59%, followed by 51.33% insiders and 38.08% retail investors. The average institutional ownership in Renovaro Biosciences's industry, Biotech Stocks , is 68.48%, which Renovaro Biosciences falls below.

Who owns the most shares of Renovaro Biosciences?

Renovaro Biosciences’s largest shareholders are Blackrock funding, inc. /de (6.5M shares, 4.15%), Vanguard group (5.72M shares, 3.65%), and Geode capital management (2.33M shares, 1.49%). Together, they hold 9.30% of Renovaro Biosciences’s total shares outstanding.

Does Blackrock own Renovaro Biosciences?

BlackRock is not among the top 10 institutional shareholders of Renovaro Biosciences.

Who is Renovaro Biosciences’s biggest shareholder by percentage of total assets invested?

Abel hall is Renovaro Biosciences’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 12.42K Renovaro Biosciences shares, valued at 10.38K$.

Who is the top mutual fund holder of Renovaro Biosciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Renovaro Biosciences shares, with 2.06% of its total shares outstanding invested in 3.34M Renovaro Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools